US3238199A - Phenothiazine compounds - Google Patents
Phenothiazine compounds Download PDFInfo
- Publication number
- US3238199A US3238199A US91603A US9160361A US3238199A US 3238199 A US3238199 A US 3238199A US 91603 A US91603 A US 91603A US 9160361 A US9160361 A US 9160361A US 3238199 A US3238199 A US 3238199A
- Authority
- US
- United States
- Prior art keywords
- ether
- added
- phenothiazine
- solution
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 title 1
- 229950000688 phenothiazine Drugs 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 156
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 144
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 64
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 48
- 239000000203 mixture Substances 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 38
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 229910000027 potassium carbonate Inorganic materials 0.000 description 32
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 31
- 238000010992 reflux Methods 0.000 description 31
- 229910052708 sodium Inorganic materials 0.000 description 31
- 239000011734 sodium Substances 0.000 description 31
- 239000003921 oil Substances 0.000 description 30
- 238000003756 stirring Methods 0.000 description 29
- 229920006395 saturated elastomer Polymers 0.000 description 22
- 239000002253 acid Substances 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 19
- 229960001701 chloroform Drugs 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 17
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 14
- -1 alkylene radicals Chemical class 0.000 description 14
- 229910052938 sodium sulfate Inorganic materials 0.000 description 14
- 235000011152 sodium sulphate Nutrition 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- RDKZDKKUPUHJSW-UHFFFAOYSA-N 1-(3-chloropropyl)-10H-phenothiazine Chemical compound ClCCCC1=CC=CC=2SC3=CC=CC=C3NC12 RDKZDKKUPUHJSW-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 description 6
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 4
- OOARYLWNROHOKX-UHFFFAOYSA-N 1-phenothiazin-10-ylpropan-2-ol Chemical compound C1=CC=C2N(CC(O)C)C3=CC=CC=C3SC2=C1 OOARYLWNROHOKX-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 3
- FMENRHNHBUWRMN-UHFFFAOYSA-N 2-phenothiazin-10-ylethanol Chemical compound C1=CC=C2N(CCO)C3=CC=CC=C3SC2=C1 FMENRHNHBUWRMN-UHFFFAOYSA-N 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000000061 acid fraction Substances 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 150000002990 phenothiazines Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229960002887 deanol Drugs 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FHDYRFNCTJFNQX-UHFFFAOYSA-N 1-(2-chloroethyl)-4-methylpiperazine Chemical compound CN1CCN(CCCl)CC1 FHDYRFNCTJFNQX-UHFFFAOYSA-N 0.000 description 1
- VKKTUDKKYOOLGG-UHFFFAOYSA-N 1-(diethylamino)propan-1-ol Chemical compound CCC(O)N(CC)CC VKKTUDKKYOOLGG-UHFFFAOYSA-N 0.000 description 1
- FROIENHSRFXVDC-UHFFFAOYSA-N 2-(2-chlorophenothiazin-10-yl)ethanol Chemical compound C1=C(Cl)C=C2N(CCO)C3=CC=CC=C3SC2=C1 FROIENHSRFXVDC-UHFFFAOYSA-N 0.000 description 1
- QHTUMQYGZQYEOZ-UHFFFAOYSA-N 2-(4-methylpiperazin-1-yl)ethanol Chemical compound CN1CCN(CCO)CC1 QHTUMQYGZQYEOZ-UHFFFAOYSA-N 0.000 description 1
- AKCDFARKBBNWNZ-UHFFFAOYSA-N 2-(4-methylpiperazin-1-yl)ethanol;hydrochloride Chemical compound Cl.CN1CCN(CCO)CC1 AKCDFARKBBNWNZ-UHFFFAOYSA-N 0.000 description 1
- VKBVRNHODPFVHK-UHFFFAOYSA-N 2-[2-(diethylamino)ethoxy]ethanol Chemical compound CCN(CC)CCOCCO VKBVRNHODPFVHK-UHFFFAOYSA-N 0.000 description 1
- YSAANLSYLSUVHB-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]ethanol Chemical compound CN(C)CCOCCO YSAANLSYLSUVHB-UHFFFAOYSA-N 0.000 description 1
- SGWITRIKWQUYGZ-UHFFFAOYSA-N 2-chloro-10-(3-chloropropyl)phenothiazine Chemical compound C1=C(Cl)C=C2N(CCCCl)C3=CC=CC=C3SC2=C1 SGWITRIKWQUYGZ-UHFFFAOYSA-N 0.000 description 1
- KFZGLJSYQXZIGP-UHFFFAOYSA-N 2-chloro-10h-phenothiazine Chemical compound C1=CC=C2NC3=CC(Cl)=CC=C3SC2=C1 KFZGLJSYQXZIGP-UHFFFAOYSA-N 0.000 description 1
- YSUZHUSIBQEHEH-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanol;hydrochloride Chemical compound Cl.OCCN1CCCC1 YSUZHUSIBQEHEH-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZZLCFHIKESPLTH-UHFFFAOYSA-N 4-Methylbiphenyl Chemical compound C1=CC(C)=CC=C1C1=CC=CC=C1 ZZLCFHIKESPLTH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000005529 alkyleneoxy group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- QJWQYOHBMUQHGZ-UHFFFAOYSA-N ethanol;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound CCO.OC(=O)CC(O)(C(O)=O)CC(O)=O QJWQYOHBMUQHGZ-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F6/00—Post-polymerisation treatments
- C08F6/02—Neutralisation of the polymerisation mass, e.g. killing the catalyst also removal of catalyst residues
Definitions
- the compounds of the invention are of the formula wherein n is a whole integer from 1 to 2; R is selected from the group consisting of hydrogen, halogen, and trifluoromethyl; A and B can be the same or different and are selected from the group consisting of straight and branched chain lower alkylene radicals; and R and R are selected from the group consisting of lower alkyl and, taken together with the nitrogen ring, a 5 to 6 membered heterocyclic ring containing 1 to 2 nitrogen atoms and a lower alkyl substituted 5 to 6 membered heterocyclic ring containing 1 to 2 nitrogen atoms.
- straight or branched chain lower alkylene refers to such radicals as and the like.
- 5 to 6 membered heterocyclic rings containing 1 to 2 nitrogen atoms are illustrated by radicals such as piperazinyl, pyrrolidyl, and the like and lower alkyl substituted 5 to 6 membered heterocyclic rings containing l to 2 nitrogen atoms are, for example, 4-methyll-piperazinyl and the like.
- the compounds corresponding to Formula I above are basic in character and form acid addition salts with inorganic or organic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, methane sul- F fomc acid, toluene sulfomc ac1d, acetic acid, succimc acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, oxalic acid, and the like.
- inorganic or organic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, methane sul- F fomc acid, toluene sulfomc ac1d, acetic acid, succimc acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, oxalic acid, and the like.
- novel compounds of the invention can be made by several different methods.
- One method comprises reacting an alkali metal salt of a 10-hydroxy-lower alkylene-phcnothiazine with a tertiary amino-lower alkylhalide to yield a IO-tertiary amino-lower alkyleneoxylower alkylene-phenothiazine.
- Another method comprises reacting a l0-halo-lower alkylene-phenothiazine with a tertiary amino-lower alkanol, in the presence of an alkali metal, such as sodium, to yield the desired product corresponding to Formula I above.
- the compounds of the invention are valuable medicinal agents, having utility as anti-emetic agents. They can also be used as central nervous system depressants and as potentiators of barbiturate hypnosis. They can be administered internally, with dosages adjusted to individual requirements, either as the free base or as a medicinally acceptable acid addition salt. They can be compounded into conventional pharmaceutical forms such as capsules, .tablets, suspensions, solutions and the like.
- Example 1 A mixture of 150 ml. of dry toluene, 11.6 g. of sodium amide, and 60 g. of phenothiazine was refluxed and stirred for 16 hours, and the reaction mixture then cooled to 60. 26.1 g. of propylene oxide, dissolved in 150 ml. of dry toluene, was added to the stirring mixture at such a rate as to maintain the temperature near 60. When the addition had been completed, the reaction mixture was heated to reflux. After 2 hours of refluxing and stirring, the reaction mixture was allowed to cool to room temperature and then washed three times with 100 ml. of water and dried over sodium sulfate.
- the desiccant was removed by filtration and the filtrate was concentrated under vacuum on a water bath to a viscous residue.
- the residue was distilled at reduced pressure to give l0-(2 hydroxypropyl)-phenothiazine as a viscous, light yellow oil; B.P. 161-163 at 0.03 mm.
- Example 2 220 g. 2-trifiuoromethylphenothiazine was added rapidly to a fine suspension of 20 g. of sodium in 1200 ml. of dry toluene. While stirring, the mixture was carefully heated to reflux temperature. After 6 hours at reflux with stirring most of the sodium had reacted, and the mixture was cooled to 80 g. of propylene oxide in ml. toluene was added slowly with stirring at such a rate that reaction temperature was maintained around 80. With the last third of the addition, external heating had to be used to maintain 80. After the addition was completed, the reaction mixture was heated with stirring to 100 and held at that temperature for an additional 2 /2 hours. For approximately 18 hours, the reaction mixture Was allowed to remain at room temperature.
- Example 3 A mixture of 100 ml. of dry toluene, 20 g. of 10-(2-hydroxyethyl)phenothiazine, and 1.9 g. sodium was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 8.7 g. of dimethylaminoethyl chloride in 50 ml. of dry toluene was added dropwise at reflux temperature. After the addition was complete, the reaction mixture was refluxed and stirred for an additional 13 hours, cooled to room temperature, and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid extract was washed two times with ether and then saturated with potassium carbonate. The alkaline mixture was then extracted with chloroform.
- the product was made into an oxalate by dissolving it in ether and adding an excess of an ether-oxalic acid solution.
- the precipitate formed was crystallized from isopropyl alcohol, M.P. 9496.
- Example 4 1.0 g. of sodium was added to a solution of 10.6 g. of 10-(2-hydroxyethyl)phenothiazine dissolved in 100 ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. 7.0 g. of diethylaminoethylchloride in 50 ml. of dry toluene was added dropwise at reflux temperature, with stirring. After the addition was completed, the reaction was refluxed and stirred for an additional 6 hours, cooled to room temperature and filtered. The filtrate was concentrated to dryness and the residue was dissolved in 300 ml. of ether. Dry hydrogen chloride was bubbled into the solution.
- a citrate was made by dissolving the distillate in ether and adding a slight excess of a concentrated citric acidalcohol solution. The precipitate was collected and crystallized from acetone and ether, M.P. 6768.
- Phenyl lithium was prepared from 50 g. of brornobenzene and 4.2 g. of lithium wire in 300 cc. of dry ether; 53.7 g. of phenothiazine was then added. The mixture was stirred at room temperature for 1 hour and ether then added to thin the thick mixture which was then cooled with ice-water. When cool 67.0 g. of 3-chloro-n-propy1-ptoluene sulfonate in cc. ether was added. Upon completion of the addition, the reaction mixture was heated toreflux for 2 hours and then cooled, reacted with cold water, and the ether solution separated after washing with water. The ether solution was then dried and concentrated to dryness and the residue crystallized with ethanol to give 10-(3-ch-loropropyDphenothiazine as crystals melting at 63-64".
- Example 7 5.9 g. of diethylarn-inoethanol was reacted with 1.2 g. sodium shot in 100 cc. of dry toluene under reflux. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. of warm toluene was then added and the mixture stirred under reflux for 24 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloroform.
- Example 8 4.5 g. of dimethylaminoethanol was added to 1.2 g. of sodium shot in 100 cc. of dry toluene and the mixture refluxed until the sodium had reacted. To this suspension was added 13.7 g. of 3-chloropropylphenothiazine in 500 cc. of dry toluene and the mixture stirred and refluxed for 24 hours. Alcohol and water were then added and basic material separated with hydrochloric acid solution. The acid solution was made basic and the oil that separated was dissolved in chloroform, Washed with water, the chloroform layer separated and dried. The resulting dried chloroform solution was concentrated to dryness and the residue distilled. An oil boiling at 196/ 0.03 mm.
- Example 9 7.2 g. of 1-methyl-4-hydroxyethyl-piperazine was reacted With 1.2 g. of sodium shot in 100 cc. of boiling toluene. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. warm toluene was added and the mixture refluxed and stirred for 24 hours, then cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid, and the acid extract washed with ether and saturated With potassium carbonate. The product was isolated by extracting the aqueous mixture with chlo roform.
- Example 10 3.3 g. of diethylaminopropanol was added to 0.06 g. of sodium in 100 cc. of dry toluene and the mixture refluxed until all the sodium had reacted. 6.9 g. of 3- chloropropylphenothiazine in 20 cc. of warm toluene was then added and the mixture stirred and refluxed for 24 hours. 100 cc. of ethanol was then added and the basic oil was extracted with 6 N hydrochloric acid. The acid layer was separated, made basic with excess potassium carbonate, and the basic oil extracted with ether. The ether solution was washed with water, dried, and concentrated to dryness.
- the thick residue was converted to the citrate, 10-[3-(3-diethylaminopropoxy)propyl]phenothiazine citrate, in alcohol and acetone, and recrystallized from acetone to give crystals melting at 76.
- Example 11 5.7 g. of dimethylaminoethoxyethanol was added to 1.2 g. of sodium shot in 100 cc. of dry toluene and the mixture was refluxed until all the sodium had reacted. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. of warm toluene was then added and the mixture stirred under reflux for 8 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid and the acid extract washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloro form.
- Example 13 1.0 g. of sodium was added to a solution of 11.0 g. of 10-(2-hydroxypropyl)phenothiazine in 100 ml. of dry toluene. All the sodium had reacted after the solution had been stirred and refluxed for 1 hour. 5.0 g. of freshly distilled dimethylaminoethylchloride in 50 ml. of dry toluene was then added dropwise, with stirring, at
- Example 14 0.9 g. of sodium was added to a solution of 10 g. of 10-(2-hydroxypropyl)phenothiazine dissolved in ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. 6 g. of freshly distilled diethylaminoethylchloride dissolved in 100 ml. dry toluene was added dropwise at reflux temperature. After this addition, the reaction mixture was refluxed for 3 hours and allowed to stand at room temperature overnight. The reaction mixture was filtered. The filtrate was concentrated under vacuum on a water bath to a viscous oil, which was distilled; B.P.
- Example 15 20.0 g. N-(Z-hydroxyethyl)-N-methyl-piperazine was added dropwise, very slowly at 100 ml. of stirring thionylchloride. After the addition was completed, the reaction was heated cautiously to reflux and held there for 1 hour. The excess thionylchloride was removed under vacuum on a water bath. 200 ml. of water was carefully added, with stirring, to the residue. The solution was then cooled, saturated with potassium carbonate, and extracted with ether. After the ether solution had been dried several hours over sodium sulfate, it was filtered and concentrated, under vacuum, on a water bath. The syrupy residue was dissolved in 50 ml.
- Example 16 0.9 g. of sodium was reacted at reflux temperature with 11.4 g. of 2 chloro 10(2 hydroxyethyl)phenothiazine that had been dissolved in 100 cc. of dry toluene. The reaction mixture was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 6.0 g. of diethylaminoethylchloride dissolved in 20 ml. of dry toluene was added dropwise, with stirring, at reflux temperature. After the addition was complete, the reaction mixture was refluxed and stirred for an additional 8 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid.
- a citrate of the reaction product was made by dissolving the distillate in ether and adding a slight excess of a concentrated citric acid-alcohol solution. The precipitate was collected on a filter and crystallized from acetone and ether yielding the crystals of the citrate salt.
- Example 1 7 3.8 g. of dimethylaminoethanol was dissolved in 50 ml. of dry toluene. To this solution 1.0 g. of sodium was added. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. Following the introduction of 15 g. of crude 2-chloro-10-(3-chloropropyl)- phenothiazine dissolved in 50 cc. of dry toluene, the reaction mixture was refluxed and stirred for an additional 16 hours and then allowed to cool to room temperature. 200 ml. of benzene was added and the resulting mixture washed 2 times with water. The organic portion was then extracted with dilute hydrochloric acid.
- the acid fraction was washed with ether and then saturated with potassium carbonate.
- the product was collected by extracting the aqueous mixture with chloroform. After the chloroform solution had been dried over sodium sulfate, it was filtered and concentrated under vacuum on a water bath to a viscous residue. The residue was distilled at reduced pressure to give 2-chloro-l0- [3 (2 dimethylaminoethoxy)propyl]phenothiazine as a viscous oil; B.P. 175200/-0.2 mm.
- a citrate was made from the product by dissolving the oil in ether and adding a slight excess of a citric acid-alcohol solution. The precipitate formed was crystallized from acetone.
- Example 18 g. of 2-chlorophenothiazine was dissolved in 100 m1. of dry toluene. To this solution 4.0 g. of sodium amide was added. The mixture was refluxed and stirred for 6 hours. 10 g. of trimethylenebromochloride was added. The reaction was again allowed to reflux and was stirred for an additional 6 hours. When the reaction had cooled to room temperature, 10 ml. of ethanol was added with stirring followed by 200 ml. of Water and 100 ml. of benzene. The organic layer was separated and washed with water. After the chloropropylphenothiazine solution had dried over sodium sulfate, it was filtered and concentrated to a syrup.
- the syrup residue was, in turn, dissolved in 50 ml. of dry toluene and added, at a reflux temperature, to a stirring mixture of 8.0 g. of the sodium salt of N-(2-hydroxyethyl)-N-methylpiperazine previously made by reacting stoichiometric amounts of metallic sodium and N-(Z-hydroxyethyl)-N'-methylpiperazine in refluxing dry toluene. After the reaction mixture had stirred and refluxed for 10 hours it was cooled to room temperature. 5.0 ml. of ethanol was then added with stirring followed by 100 ml. of water and 200 ml. of ether. The organic layer was separated and washed with water. It was then extracted with dilute hydrochloric acid.
- the acid portion was, in turn, saturated with potassium carbonate and the product collected by an ether extraction. After the ether solution had dried over sodium sulfate, it was filtered and concentrated. The filtrate was distilled at reduced pressure to give 2-chloro- 10 ⁇ 3 [2 (4 methyl 1 piperazinyl)ethoxy1propyl ⁇ phenothiazine as a viscous oil; B.P. 120-122" at 0.35 mm.; however, there was considerable decomposition during the distillation. The crude oil was then dissolved in ether and a slight excess of a citric acid-alcohol solution was added. The product formed was crystallized from acetone, M.P. 120122 (uncorr.).
- Example 19 10.0 g. of 2-chloro-1-(Z-hydroxypropyl)phenothiazine was dissolved in ml. of dry toluene. To this solution, 0.8 g. of sodium was added. The mixture was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 7.0 g. of dimethylaminoethylchloride dissolved in 50 ml. of dry toluene was added dropwise, with stirring, to the refluxing reaction mixture. After all the dimethylaminoethylchloride had been introduced, the reaction was refluxed and stirred for an additional 11 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid.
- the acid fraction was washed with ether and then saturated with potassium carbonate.
- the product was collected by extracting the aqueous mixture with ether. After the ether solution had been dried over potassium carbonate, it was filtered and the filtrate was concentrated under vacuum to give a viscous residue. The residue was distilled at reduced pressure to give 2-chloro-l0-[2-(Z-dimethylaminoethoxy) propyllphenothiazine as a viscous yellow oil; B.P. 191- 200 at 0.08 mm.
- a citrate was made by dissolving the oil in ether and adding a slight excess of a citric acidalcohol solution. The precipitate that formed was crystallized from acetone; M.P. 9395 (uncorr.).
- Example 20 15.0 of 2-chloro-l0-(2-hydroxypropyl)phenothiazine was dissolved in 70.0 ml. of dry toluene. To this solution 2.0 g. of sodium amide was added. The resulting mixture was refluxed and stirred for 2 hours. Then, 23.6 g. of N-(Z-chloroethyl)- I'-methylpiperazine was added with stirring at reflux temperature. After the reaction had refluxed and stirred for 7 hours, it was allowed to cool to room temperature. 200 ml. of water followed by 300 ml. of ether was added to the stirring mixture. The organic portion was separated and extracted with dilute hydrochloric acid.
- the acid extract was washed with ether and saturated with potassium carbonate.
- the product was collected by extracting the alkaline mixture with ether. After the ether solution had dried over po tassium carbonate, it was filtered and concentrated under vacuum, on a water bath, to a syrup. The syrup was distilled at reduced pressure to give 2-chloro-l0 ⁇ 2-[2-(4- methyl-l-piperazinyl)ethoxy]propyl ⁇ phenothiazine as a light yellow viscous oil; B.P. 200-220 at 0.3 mm.
- a hydrochloride was made by dissolving the base in ether and saturating the ether solution with dry hydrochloride. The precipitate was crystallized from a combination of methanol and ethyl acetate and gave the hydrochloride salt; M.P. 239-240 (uncorr.).
- N-(2-chloroethyl)-N-methylpiperazine used above was made by reacting 25.0 g. of N-(2-hydroxyethyl)-N'- methylpiperazine hydrochloride in a 100 ml. of refluxing thionyl chloride. The excess thionyl chloride was removed under vacuum, on a water bath, and the residue was dissolved in 100 ml. of water, saturated with potassium carbonate, and extracted with ether. After the ether solution had dried over sodium sulfate for several hours, it was filtered and concentrated, yielding N-(2- chloroethyl)-N-methylpiperazine as a syrup.
- Example 22 0.85 g. of sodium was added to a solution of 11.2 g. of Z-trifluoromethyl-10-(2-hydroxypropyl)phenothiazine in 50 ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 13 hours. Then, 25 g. of N-(2-chloroethyl)-N'-methylpiperazine (made by reacting 44 g. N-(Z-hydroxyethyl)-N'-methylpiperazine hydrochloride with 200 ml. of thionyl chloride at reflux temperature), in 50 ml, of dry toluene, was added at reflux temperature with stirring.
- N-(2-chloroethyl)-N'-methylpiperazine made by reacting 44 g. N-(Z-hydroxyethyl)-N'-methylpiperazine hydrochloride with 200 ml. of thionyl chloride at reflux temperature
- the reaction mixture was refluxed and stirred an additional 10 hours. After the reaction had cooled to room temperature, 20 ml. of ethanol was added with stirring, followed by 200 ml. of water and 300 m1. of benzene. The organic portion was separated and in turn washed two times with 100 ml. of water and then extracted with dilute hydrochloric acid. The acid extract was washed once with ether and then saturated with potassium carbonate. Finally, the alkaline mixture was extracted with ether. After the ether solution had dried over sodium sulfate, it was filtered and concentrated.
- a citrate was made by dissolving the base in ether and adding a slight excess of an alcoholic solution of citric acid. The precipitate was crystallized from acetone yielding crystals of the salt melting at 150-152 (uncorr.).
- N-(Z-chloroethyl)pyrrolidine was made by reacting 67 g. of N-(2-hydroxyethyl)pyrrolidine hydrochloride in 200 ml. of refluxing thionyl chloride. The excess thionyl chloride was removed under vacuum on a water bath. The residue was dissolved in 200 ml. of water plus 100 g. of ice, saturated with potassium carbonate, and extracted with ether. After the solution had dried over sodium sulfate for several hours, it was filtered and concentrated yielding crude N-(2-chloroethyl)-pyrrolidine as a syrup.
- Example 24 A mixture of 52 g. Z-trifluoromethyl-l-(2-hydroxypropyl)-phenothiazine, 120 ml. dry toluene, and 6.2 g. of sodium amide was stirred at room temperature for 0.5 hour and then heated slowly to reflux. After all the sodium amide had reacted (ca. 2 hours), 58 g. of crude N-(2-chloroethyl)pyrrolidine in 80 ml. of dry toluene was added dropwise with stirring at reflux temperature. After the reaction had refluxed and stirred for 12 hours, it
- the hydrochloride was obtained by dissolving the distillate in ether and bubbling dry hydrogen chloride into the solution. A mixture of ethyl acetate and methanol was used to crystallize the crude hydrochloride; M.P. 164-165" (uncorr.).
- Example 25 2.4 g. of sodium amide was added to a solution of 20 g. of 2-trifluoromethyl-10-(Z-hydroxypropyl)phenothiazine in ml. of dry toluene. The resulting mixture was carefully heated (some effervescence), with stirring, to reflux. After the reaction had refluxed and stirred for 2 hours and all the sodium amide had reacted, 20 g. dimethylaminoethyl chloride in 100 ml. of dry toluene was added dropwise. The mixture was allowed to reflux and was stirred for an additional 18 hours. When the reaction mixture had cooled to room temperature, 10 ml. of ethanol was added with stirring, followed by 100 ml. of water and 200 ml.
- citric acid in 10 ml. of water.
- the solution was concentrated to dryness and 300 ml. of fresh acetone was added.
- the solution was set in the refrigerator for several days and then filtered; the resulting citrate melted at 102104 (uncorr.).
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Description
United States Patent 3,238,199 PHENOTHIAZINE COMPOUNDS Leo Berger, Montclair, Alfred John Corraz, Packanack Lake, and John Lee, Montclair, NJ., assignors to Hoffmann-La Roche Inc, Nutley, NJ., a corporation of New Jersey N0 Drawing. Filed Feb. 27, 1961, Ser. No. 91,603 Claims. (Cl. 260-243) 2: This invention relates to novel phenothiazine compounds which have utility as medicinal agents. The phenothiazine compounds of the invention are characterized by a side chain in the l0-position which, in addition to having an ether linkage, also contains a nitrogen atom. More specifically, the compounds of the invention are of the formula wherein n is a whole integer from 1 to 2; R is selected from the group consisting of hydrogen, halogen, and trifluoromethyl; A and B can be the same or different and are selected from the group consisting of straight and branched chain lower alkylene radicals; and R and R are selected from the group consisting of lower alkyl and, taken together with the nitrogen ring, a 5 to 6 membered heterocyclic ring containing 1 to 2 nitrogen atoms and a lower alkyl substituted 5 to 6 membered heterocyclic ring containing 1 to 2 nitrogen atoms.
As used in this disclosure, the term straight or branched chain lower alkylene refers to such radicals as and the like. 5 to 6 membered heterocyclic rings containing 1 to 2 nitrogen atoms are illustrated by radicals such as piperazinyl, pyrrolidyl, and the like and lower alkyl substituted 5 to 6 membered heterocyclic rings containing l to 2 nitrogen atoms are, for example, 4-methyll-piperazinyl and the like.
The compounds corresponding to Formula I above are basic in character and form acid addition salts with inorganic or organic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, methane sul- F fomc acid, toluene sulfomc ac1d, acetic acid, succimc acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, oxalic acid, and the like. These medicinally acceptable acid addition salts are part of the invention.
Side chains Within the scope of the invention, conforming to the grouping Patented Mar. 1, 1966 the invention are those under Formula I above wherein A represents the group Especially preferred are those compounds wherein R and R taken together with the nitrogen atom, represent 4-methyl-1-piperazinyl. Also preferred are those compounds wherein R is trifiuoromethyl.
The novel compounds of the invention can be made by several different methods. One method comprises reacting an alkali metal salt of a 10-hydroxy-lower alkylene-phcnothiazine with a tertiary amino-lower alkylhalide to yield a IO-tertiary amino-lower alkyleneoxylower alkylene-phenothiazine. Another method comprises reacting a l0-halo-lower alkylene-phenothiazine with a tertiary amino-lower alkanol, in the presence of an alkali metal, such as sodium, to yield the desired product corresponding to Formula I above.
The compounds of the invention are valuable medicinal agents, having utility as anti-emetic agents. They can also be used as central nervous system depressants and as potentiators of barbiturate hypnosis. They can be administered internally, with dosages adjusted to individual requirements, either as the free base or as a medicinally acceptable acid addition salt. They can be compounded into conventional pharmaceutical forms such as capsules, .tablets, suspensions, solutions and the like.
The following examples are illustrative of the invention but not limitative thereof. All temperatures are in degrees centigrade.
Example 1 A mixture of 150 ml. of dry toluene, 11.6 g. of sodium amide, and 60 g. of phenothiazine was refluxed and stirred for 16 hours, and the reaction mixture then cooled to 60. 26.1 g. of propylene oxide, dissolved in 150 ml. of dry toluene, was added to the stirring mixture at such a rate as to maintain the temperature near 60. When the addition had been completed, the reaction mixture was heated to reflux. After 2 hours of refluxing and stirring, the reaction mixture was allowed to cool to room temperature and then washed three times with 100 ml. of water and dried over sodium sulfate. The desiccant was removed by filtration and the filtrate was concentrated under vacuum on a water bath to a viscous residue. The residue was distilled at reduced pressure to give l0-(2 hydroxypropyl)-phenothiazine as a viscous, light yellow oil; B.P. 161-163 at 0.03 mm.
Example 2 220 g. 2-trifiuoromethylphenothiazine was added rapidly to a fine suspension of 20 g. of sodium in 1200 ml. of dry toluene. While stirring, the mixture was carefully heated to reflux temperature. After 6 hours at reflux with stirring most of the sodium had reacted, and the mixture was cooled to 80 g. of propylene oxide in ml. toluene was added slowly with stirring at such a rate that reaction temperature was maintained around 80. With the last third of the addition, external heating had to be used to maintain 80. After the addition was completed, the reaction mixture was heated with stirring to 100 and held at that temperature for an additional 2 /2 hours. For approximately 18 hours, the reaction mixture Was allowed to remain at room temperature. It was then cooled to +10 with stirring and 60 ml. of ethanol added, followed by 300 ml. of water and 500 ml. of ether. The organic portion was separated, washed with 300 ml. of water 5 times, and the solvent layer separated again and dried over anhydrous sodium sulfate. The desiccant was removed by filtration, the filtrate concentrated to dryness on a water bath at reduced pressure and the residue was 3 distilled yielding Z-trifluoromethyl-l-(2-hydroxypropyl) phenothiazine, B.P. 172-175/0.2 mm.
2-chloro-10-(Z-hydroxypropyl)phenothiazine, 10 (2- hydroxyethyl)phenothiazine, and 2-chloro-10-(2-hydroxyethyl) phenothiazine were also made by the procedure illustrated in Examples 1 and 2 above.
Example 3 A mixture of 100 ml. of dry toluene, 20 g. of 10-(2-hydroxyethyl)phenothiazine, and 1.9 g. sodium was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 8.7 g. of dimethylaminoethyl chloride in 50 ml. of dry toluene was added dropwise at reflux temperature. After the addition was complete, the reaction mixture was refluxed and stirred for an additional 13 hours, cooled to room temperature, and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid extract was washed two times with ether and then saturated with potassium carbonate. The alkaline mixture was then extracted with chloroform. When the chloroform extract had been dried over sodium sulfate for 24 hours, it was filtered and the filtrate was concentrated to a syrupy residue under vacuum. The residue was distilled at reduced pressure to give l0-[2-(Z-dimethylaminoethoxy) ethyllphenothi-azine as a viscous oil; BrP. 191-199 at 0.15 mm.
The product was made into an oxalate by dissolving it in ether and adding an excess of an ether-oxalic acid solution. The precipitate formed was crystallized from isopropyl alcohol, M.P. 9496.
Example 4 1.0 g. of sodium was added to a solution of 10.6 g. of 10-(2-hydroxyethyl)phenothiazine dissolved in 100 ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. 7.0 g. of diethylaminoethylchloride in 50 ml. of dry toluene was added dropwise at reflux temperature, with stirring. After the addition was completed, the reaction was refluxed and stirred for an additional 6 hours, cooled to room temperature and filtered. The filtrate was concentrated to dryness and the residue was dissolved in 300 ml. of ether. Dry hydrogen chloride was bubbled into the solution. The supernatant mother liquor was decanted and the oily residue was washed 3 times with ether, then was dissolved in water and the resulting solution saturated with potassium carbonate and extracted with chloroform. When the chloroform extract had dried over sodium sulfate, it was filtered and concentrated. The residue was distilled at reduced pressure to give 10-[2-(Z-diethylaminoethoxy)ethyl]phenothiazine as a yellow viscous oil; B.P. 193221 at 0.1 mm.
A citrate was made by dissolving the distillate in ether and adding a slight excess of a concentrated citric acidalcohol solution. The precipitate was collected and crystallized from acetone and ether, M.P. 6768.
Example 20 g. N-(Z-hydroxyethyl)-N'-methyl-piperazine was added dropwise, very slowly, to 100 ml. of stirring thionyl chloride. After the addition was complete, the reaction was heated cautiously to reflux and held there for 1 hour. The excess thionyl chloride was removed under vacuum on a water bath. 200 ml. of water was carefully added, with stirring, to the residue. The solution was then cooled, saturated with potassium carbonate, and extracted with ether. After the ether solution had dried over sodium sulfate for several hours, it was filtered and the filtrate concentrated under vacuum on a water bath. The residue was dissolved in 50 ml. of dry toluene and the solution was added to a refluxing and stirring mixture of 16.3 g. of the sodium salt of -(2-hydroxyethyl)phenothiazine in 100 ml. of dry toluene. After the reaction had refluxed and stirred for 16 hours, it was cooled to room temperature and washed by extraction with water. The
reaction was then extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and saturated with potassium carbonate. The alkaline mixture that formed was then extracted with ether. After the ether solution had been dried over sodium sulfate, it was filtered, and a slight excess of an ether solution of maleic acid was added. The precipitate was filtered and recrystallized from ethanol to give 10-{2-[2*(4-methyl1- piperazinyl)ethoxy]ethyl}phenothiazine dimaleate, M.P. l64-166 (uncorr.).
Example 6 Phenyl lithium was prepared from 50 g. of brornobenzene and 4.2 g. of lithium wire in 300 cc. of dry ether; 53.7 g. of phenothiazine was then added. The mixture was stirred at room temperature for 1 hour and ether then added to thin the thick mixture which was then cooled with ice-water. When cool 67.0 g. of 3-chloro-n-propy1-ptoluene sulfonate in cc. ether was added. Upon completion of the addition, the reaction mixture was heated toreflux for 2 hours and then cooled, reacted with cold water, and the ether solution separated after washing with water. The ether solution was then dried and concentrated to dryness and the residue crystallized with ethanol to give 10-(3-ch-loropropyDphenothiazine as crystals melting at 63-64".
Example 7 5.9 g. of diethylarn-inoethanol was reacted with 1.2 g. sodium shot in 100 cc. of dry toluene under reflux. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. of warm toluene was then added and the mixture stirred under reflux for 24 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloroform. After the chloroform solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum on a water bath to a viscous oil, which was then distilled to give the product, 10-[3- Z-diethylaminoethoxy)propyl]phenothiazine, as an oil boiling at 200/.02 mm. Conversion to a citrate salt in alcohol-ether, yielded crystals which, after further recrystallization from acetone, melted at 8890.
Example 8 4.5 g. of dimethylaminoethanol was added to 1.2 g. of sodium shot in 100 cc. of dry toluene and the mixture refluxed until the sodium had reacted. To this suspension was added 13.7 g. of 3-chloropropylphenothiazine in 500 cc. of dry toluene and the mixture stirred and refluxed for 24 hours. Alcohol and water were then added and basic material separated with hydrochloric acid solution. The acid solution was made basic and the oil that separated was dissolved in chloroform, Washed with water, the chloroform layer separated and dried. The resulting dried chloroform solution was concentrated to dryness and the residue distilled. An oil boiling at 196/ 0.03 mm. was collected which was dissolved in acetone and converted to a hydrochloride with alcoholic hydrochloric acid. Ether was added to induce crystallization. Crystals of 10[3-(Z-dimethylaminoethoxy)propyl]phenothiazine hydrochloride were obtained.
Example 9 7.2 g. of 1-methyl-4-hydroxyethyl-piperazine was reacted With 1.2 g. of sodium shot in 100 cc. of boiling toluene. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. warm toluene was added and the mixture refluxed and stirred for 24 hours, then cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid, and the acid extract washed with ether and saturated With potassium carbonate. The product was isolated by extracting the aqueous mixture with chlo roform. After the chloroform solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum on a water bath to a thick syrup that did not distill at 0.08 mm. This thick basic residue was converted to a hydrochloride salt in alcohol with alcoholic hydrochloric acid and recrystallized from ethyl acetate-methanol, yielding crystals of -{3-[2-(4-methyll-piperazinyl) ethoxy] propyl}ph-enothiazine dihydrochloride melting at 201202.
Example 10 3.3 g. of diethylaminopropanol was added to 0.06 g. of sodium in 100 cc. of dry toluene and the mixture refluxed until all the sodium had reacted. 6.9 g. of 3- chloropropylphenothiazine in 20 cc. of warm toluene was then added and the mixture stirred and refluxed for 24 hours. 100 cc. of ethanol was then added and the basic oil was extracted with 6 N hydrochloric acid. The acid layer was separated, made basic with excess potassium carbonate, and the basic oil extracted with ether. The ether solution was washed with water, dried, and concentrated to dryness. The thick residue was converted to the citrate, 10-[3-(3-diethylaminopropoxy)propyl]phenothiazine citrate, in alcohol and acetone, and recrystallized from acetone to give crystals melting at 76.
Example 11 5.7 g. of dimethylaminoethoxyethanol was added to 1.2 g. of sodium shot in 100 cc. of dry toluene and the mixture was refluxed until all the sodium had reacted. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. of warm toluene was then added and the mixture stirred under reflux for 8 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid and the acid extract washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloro form. After the chloroform solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum on a water bath to a viscous oil, which was distilled to yield an oil boiling at 205207/0.07 mm. This basic oil was converted to a hydrochloride salt with alcoholic hydrochloric acid and recrystallized from ethyl acetate-methanol to yield crystals of 10-{3-[2-(2- dimethylaminoethoxy)ethoxy]propyl}phenothiazine hydrochloride melting at 122.5-123 Example 12 8.1 g. of diethylaminoethoxyethanol was added to 1.2 g. of sodium shot in 100 cc. of dry toluene and the mixture refluxed until all the sodium had reacted. 13.7 g. of 3-chloropropylphenothiazine in 50 cc. of warm toluene was then added and the mixture stirred and refluxed for 8 hours, then cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid and the acid extract washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloroform. After the chloroform solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum on a water bath to a viscous oil, which was then distilled in vacuum yielding, as a thick oil boiling at 2l2219/0.08 mm., l0{3-[2-(2-diethylaminoethoxy)ethoxy] propyl}pher1othiazine citrate, which gave an amorphous hydrochloride. A crystalline citrate was prepared and when recrystallized from acetone, crystals of the citrate melting at 98l00 were obtained.
Example 13 1.0 g. of sodium was added to a solution of 11.0 g. of 10-(2-hydroxypropyl)phenothiazine in 100 ml. of dry toluene. All the sodium had reacted after the solution had been stirred and refluxed for 1 hour. 5.0 g. of freshly distilled dimethylaminoethylchloride in 50 ml. of dry toluene was then added dropwise, with stirring, at
reflux temperature. The reaction mixture was then stirred and refluxed for an additional 18 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and then saturated with potassium carbonate. The product was isolated by extracting the aqueous mixture with chloroform. After the chloroform solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum on a water bath to a viscous oil. The oil was then distilled under vacuum to give 10-[2-(2-dimethylaminoethoxy)propyl]phenothiazine as a viscous light yellow oil; B.P. 190192 at 0.15 mm. An oxalate was made of the product by dissolving the oil in ether and adding a slight excess of an oxalic acid-ether solution. The precipitate that formed was recrystallized from acetone and ether.
Example 14 0.9 g. of sodium was added to a solution of 10 g. of 10-(2-hydroxypropyl)phenothiazine dissolved in ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. 6 g. of freshly distilled diethylaminoethylchloride dissolved in 100 ml. dry toluene was added dropwise at reflux temperature. After this addition, the reaction mixture was refluxed for 3 hours and allowed to stand at room temperature overnight. The reaction mixture was filtered. The filtrate was concentrated under vacuum on a water bath to a viscous oil, which was distilled; B.P. 187-192" at 0.07 mm., yielding 10[2-(2-diethylaminoethoxy)propyl]-phenothiazine as a light yellow, viscous oil. A solid product was prepared by dissolving the base in ether and adding a slight excess of a concentrated alcoholic solution of citric acid. The citrate was crystallized 2 times from acetone and ether.
Example 15 20.0 g. N-(Z-hydroxyethyl)-N-methyl-piperazine was added dropwise, very slowly at 100 ml. of stirring thionylchloride. After the addition was completed, the reaction was heated cautiously to reflux and held there for 1 hour. The excess thionylchloride was removed under vacuum on a water bath. 200 ml. of water was carefully added, with stirring, to the residue. The solution was then cooled, saturated with potassium carbonate, and extracted with ether. After the ether solution had been dried several hours over sodium sulfate, it was filtered and concentrated, under vacuum, on a water bath. The syrupy residue was dissolved in 50 ml. of dry toluene, and the resulting solution added to a refluxing and stirring mixture of 100 ml. of dry toluene and 11.0 g. of the sodium salt of 10-(2-hydroxypropyl)phenothiazine, previously made by reacting stoichiometric amounts of metallic sodium and 10-(2-hydroxypropyl)phenothiazine in dry toluene. When the reaction mixture had refluxed and stirred 8 hours, it was cooled to room temperature and washed with water. The organic portion was then extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and saturated with potassium carbonate. The product was collected by extracting the aqueous mixture with ether. After the ether solution had dried over sodium sulfate, it was filtered and concentrated under vacuum on a water bath, to a viscous residue. The crude product was dissolved in dry ethanol, boiled with charcoal and filtered. A slight excess of a citric acid-ethanol solution was added. 'In order to induce precipitation, several volumes of ether were added. The precipitate that formed was filtered off and recrystallized from isopropanol yielding 10-{2-[2-(4-methyl-1-piperazinyl)ethoxy]propyl}phenothiazine citrate, M.P. 87-89 (uncorr.).
Example 16 0.9 g. of sodium was reacted at reflux temperature with 11.4 g. of 2 chloro 10(2 hydroxyethyl)phenothiazine that had been dissolved in 100 cc. of dry toluene. The reaction mixture was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 6.0 g. of diethylaminoethylchloride dissolved in 20 ml. of dry toluene was added dropwise, with stirring, at reflux temperature. After the addition was complete, the reaction mixture was refluxed and stirred for an additional 8 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid fraction was washed with ether and saturated with potassium carbonate. The product was collected by extracting the aqueous mixture with chloroform. After the ether solution had been dried over potassium carbonate, it was filtered and concentrated under vacuum to an oily residue. The oil was distilled at reduced pressure to give 2-chloro-l0- [2-(2-diethylaminoethoxy)ethyl]phenothiazine as a light yellow, viscous oil; B.P. 210214 at 0.15 mm.
A citrate of the reaction product was made by dissolving the distillate in ether and adding a slight excess of a concentrated citric acid-alcohol solution. The precipitate was collected on a filter and crystallized from acetone and ether yielding the crystals of the citrate salt.
Example 1 7 3.8 g. of dimethylaminoethanol was dissolved in 50 ml. of dry toluene. To this solution 1.0 g. of sodium was added. The mixture was refluxed and stirred until all the sodium had reacted, ca. 2 hours. Following the introduction of 15 g. of crude 2-chloro-10-(3-chloropropyl)- phenothiazine dissolved in 50 cc. of dry toluene, the reaction mixture was refluxed and stirred for an additional 16 hours and then allowed to cool to room temperature. 200 ml. of benzene was added and the resulting mixture washed 2 times with water. The organic portion was then extracted with dilute hydrochloric acid. In turn, the acid fraction was washed with ether and then saturated with potassium carbonate. The product was collected by extracting the aqueous mixture with chloroform. After the chloroform solution had been dried over sodium sulfate, it was filtered and concentrated under vacuum on a water bath to a viscous residue. The residue was distilled at reduced pressure to give 2-chloro-l0- [3 (2 dimethylaminoethoxy)propyl]phenothiazine as a viscous oil; B.P. 175200/-0.2 mm. A citrate was made from the product by dissolving the oil in ether and adding a slight excess of a citric acid-alcohol solution. The precipitate formed was crystallized from acetone.
Example 18 g. of 2-chlorophenothiazine was dissolved in 100 m1. of dry toluene. To this solution 4.0 g. of sodium amide was added. The mixture was refluxed and stirred for 6 hours. 10 g. of trimethylenebromochloride was added. The reaction was again allowed to reflux and was stirred for an additional 6 hours. When the reaction had cooled to room temperature, 10 ml. of ethanol was added with stirring followed by 200 ml. of Water and 100 ml. of benzene. The organic layer was separated and washed with water. After the chloropropylphenothiazine solution had dried over sodium sulfate, it was filtered and concentrated to a syrup. The syrup residue was, in turn, dissolved in 50 ml. of dry toluene and added, at a reflux temperature, to a stirring mixture of 8.0 g. of the sodium salt of N-(2-hydroxyethyl)-N-methylpiperazine previously made by reacting stoichiometric amounts of metallic sodium and N-(Z-hydroxyethyl)-N'-methylpiperazine in refluxing dry toluene. After the reaction mixture had stirred and refluxed for 10 hours it was cooled to room temperature. 5.0 ml. of ethanol was then added with stirring followed by 100 ml. of water and 200 ml. of ether. The organic layer was separated and washed with water. It was then extracted with dilute hydrochloric acid. The acid portion was, in turn, saturated with potassium carbonate and the product collected by an ether extraction. After the ether solution had dried over sodium sulfate, it was filtered and concentrated. The filtrate was distilled at reduced pressure to give 2-chloro- 10 {3 [2 (4 methyl 1 piperazinyl)ethoxy1propyl} phenothiazine as a viscous oil; B.P. 120-122" at 0.35 mm.; however, there was considerable decomposition during the distillation. The crude oil was then dissolved in ether and a slight excess of a citric acid-alcohol solution was added. The product formed was crystallized from acetone, M.P. 120122 (uncorr.).
Example 19 10.0 g. of 2-chloro-1-(Z-hydroxypropyl)phenothiazine was dissolved in ml. of dry toluene. To this solution, 0.8 g. of sodium was added. The mixture was refluxed and stirred until all the sodium had reacted, ca. 3 hours. 7.0 g. of dimethylaminoethylchloride dissolved in 50 ml. of dry toluene was added dropwise, with stirring, to the refluxing reaction mixture. After all the dimethylaminoethylchloride had been introduced, the reaction was refluxed and stirred for an additional 11 hours, cooled to room temperature and filtered. The filtrate was extracted with dilute hydrochloric acid. In turn, the acid fraction was washed with ether and then saturated with potassium carbonate. The product was collected by extracting the aqueous mixture with ether. After the ether solution had been dried over potassium carbonate, it was filtered and the filtrate was concentrated under vacuum to give a viscous residue. The residue was distilled at reduced pressure to give 2-chloro-l0-[2-(Z-dimethylaminoethoxy) propyllphenothiazine as a viscous yellow oil; B.P. 191- 200 at 0.08 mm. A citrate was made by dissolving the oil in ether and adding a slight excess of a citric acidalcohol solution. The precipitate that formed was crystallized from acetone; M.P. 9395 (uncorr.).
Example 20 15.0 of 2-chloro-l0-(2-hydroxypropyl)phenothiazine was dissolved in 70.0 ml. of dry toluene. To this solution 2.0 g. of sodium amide was added. The resulting mixture was refluxed and stirred for 2 hours. Then, 23.6 g. of N-(Z-chloroethyl)- I'-methylpiperazine was added with stirring at reflux temperature. After the reaction had refluxed and stirred for 7 hours, it was allowed to cool to room temperature. 200 ml. of water followed by 300 ml. of ether was added to the stirring mixture. The organic portion was separated and extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and saturated with potassium carbonate. The product was collected by extracting the alkaline mixture with ether. After the ether solution had dried over po tassium carbonate, it was filtered and concentrated under vacuum, on a water bath, to a syrup. The syrup was distilled at reduced pressure to give 2-chloro-l0{2-[2-(4- methyl-l-piperazinyl)ethoxy]propyl}phenothiazine as a light yellow viscous oil; B.P. 200-220 at 0.3 mm. A hydrochloride was made by dissolving the base in ether and saturating the ether solution with dry hydrochloride. The precipitate was crystallized from a combination of methanol and ethyl acetate and gave the hydrochloride salt; M.P. 239-240 (uncorr.).
The N-(2-chloroethyl)-N-methylpiperazine used above was made by reacting 25.0 g. of N-(2-hydroxyethyl)-N'- methylpiperazine hydrochloride in a 100 ml. of refluxing thionyl chloride. The excess thionyl chloride was removed under vacuum, on a water bath, and the residue was dissolved in 100 ml. of water, saturated with potassium carbonate, and extracted with ether. After the ether solution had dried over sodium sulfate for several hours, it was filtered and concentrated, yielding N-(2- chloroethyl)-N-methylpiperazine as a syrup.
Example 21 12.0 g. of 2-chloro-l0-(2-hydroxypropyl)phenothiazine was dissolved in 100 cc. of dry toluene. To this solution 1.7 g. of sodium amide Was added. After the reaction mixture had stirred and refluxed for 2 hours, 10.0 g. of dimethylarninoisopropylchloride dissolved in 25.0 ml. of dry toluene was added dropwise at reflux temperature. When the reaction had refluxed and stirred an additional 10 hours, it was allowed to cool to room temperature. 20.0 ml. of ethanol was added with stirring, followed by 200 ml. of water and 200 ml. of ether. The organic layer was separated, washed with ether and extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether and then saturated with potassium carbonate. The product was collected by extracting the aqueous mixture with ether. After the ether solution had dried over potassium carbonate, it was filtered and concentrated under vacuum, on a water bath, to a viscous residue. The residue was distilled at reduced pressure to give 2-chloro-10-[2-(Z-dimethylaminoisopropoxy)propyl]phenothiazine as a viscous oil; B.P. 202- 207 at 0.2 mm. A citrate was made by dissolving the base in ether and adding a slight excess of a citric acidalcohol solution. The precipitate was crystallized by dissolving it in acetone, filtering, and adding several volumes of ethyl acetate; M.P. 7879 (uncorr.).
Example 22 0.85 g. of sodium was added to a solution of 11.2 g. of Z-trifluoromethyl-10-(2-hydroxypropyl)phenothiazine in 50 ml. of dry toluene. The mixture was refluxed and stirred until all the sodium had reacted, ca. 13 hours. Then, 25 g. of N-(2-chloroethyl)-N'-methylpiperazine (made by reacting 44 g. N-(Z-hydroxyethyl)-N'-methylpiperazine hydrochloride with 200 ml. of thionyl chloride at reflux temperature), in 50 ml, of dry toluene, was added at reflux temperature with stirring. The reaction mixture was refluxed and stirred an additional 10 hours. After the reaction had cooled to room temperature, 20 ml. of ethanol was added with stirring, followed by 200 ml. of water and 300 m1. of benzene. The organic portion was separated and in turn washed two times with 100 ml. of water and then extracted with dilute hydrochloric acid. The acid extract was washed once with ether and then saturated with potassium carbonate. Finally, the alkaline mixture was extracted with ether. After the ether solution had dried over sodium sulfate, it was filtered and concentrated. The residue was distilled at reduced pressure to give Z-trifluoromethyl-lO-{Z- [2-(4-methyl-1-piperazinyl) ethoxy]propyl}phenothiazine, B.P. 185190 at 0.25 mm.
A citrate was made by dissolving the base in ether and adding a slight excess of an alcoholic solution of citric acid. The precipitate was crystallized from acetone yielding crystals of the salt melting at 150-152 (uncorr.).
Example 23 N-(Z-chloroethyl)pyrrolidine was made by reacting 67 g. of N-(2-hydroxyethyl)pyrrolidine hydrochloride in 200 ml. of refluxing thionyl chloride. The excess thionyl chloride was removed under vacuum on a water bath. The residue was dissolved in 200 ml. of water plus 100 g. of ice, saturated with potassium carbonate, and extracted with ether. After the solution had dried over sodium sulfate for several hours, it was filtered and concentrated yielding crude N-(2-chloroethyl)-pyrrolidine as a syrup.
Example 24 A mixture of 52 g. Z-trifluoromethyl-l-(2-hydroxypropyl)-phenothiazine, 120 ml. dry toluene, and 6.2 g. of sodium amide was stirred at room temperature for 0.5 hour and then heated slowly to reflux. After all the sodium amide had reacted (ca. 2 hours), 58 g. of crude N-(2-chloroethyl)pyrrolidine in 80 ml. of dry toluene was added dropwise with stirring at reflux temperature. After the reaction had refluxed and stirred for 12 hours, it
was allowed to cool to room temperature. 150 ml. of water and 2000 ml. of ether were added to the stirring mixture. The organic portion was separated and extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether, saturated with potassium carbonate, and extracted again with ether. After the ether extract had dried over potassium carbonate, it was filtered and concentrated to a viscous syrup under vacuum. The residue was distilled, giving 2-trifluoromethyl-10- {2-[2-(l-pyrrolidyl)-ethoxy]propyl}phenothiazine as a glassy solid; B.P. 199200/O.2 mm., a 1.5674. The hydrochloride was obtained by dissolving the distillate in ether and bubbling dry hydrogen chloride into the solution. A mixture of ethyl acetate and methanol was used to crystallize the crude hydrochloride; M.P. 164-165" (uncorr.).
Example 25 2.4 g. of sodium amide was added to a solution of 20 g. of 2-trifluoromethyl-10-(Z-hydroxypropyl)phenothiazine in ml. of dry toluene. The resulting mixture was carefully heated (some effervescence), with stirring, to reflux. After the reaction had refluxed and stirred for 2 hours and all the sodium amide had reacted, 20 g. dimethylaminoethyl chloride in 100 ml. of dry toluene was added dropwise. The mixture was allowed to reflux and was stirred for an additional 18 hours. When the reaction mixture had cooled to room temperature, 10 ml. of ethanol was added with stirring, followed by 100 ml. of water and 200 ml. of ether. The organic portion was separated, washed with water, and then extracted with dilute hydrochloric acid. In turn, the acid extract was washed with ether, saturated with potassium carbonate, and again extracted with ether. After the ether extract had dried over sodium sulfate, the desiccant was removed by filtration and the filtrate concentrated under vacuum on a water bath. The syrupy residue was distilled at reduced pressure to give Z-trifluoromethyl-IO- [2-( Z-dimethylaminoethoxy )propyl1phenothiazine as a light yellow, viscous oil, B.P. 176177/0.05 mm. A citrate was made by dissolving the distillate in 300 ml. acetone and adding 8 g. of citric acid in 10 ml. of water. In order to induce crystallization, the solution was concentrated to dryness and 300 ml. of fresh acetone was added. The solution was set in the refrigerator for several days and then filtered; the resulting citrate melted at 102104 (uncorr.).
We claim:
1. 2-trifluoromethyl-10-{2-[(4-lower alkyl 1 piperazinyl -lower alkyleneoxy] -propyl}-phenothiazine.
2. A compound selected from the group consisting of compounds of the formula sisting of straight and branched chain lower alkylene radicals; the moiety is selected from the group consisting of unsubstituted and lower alkyl-substituted l-pyrrolidyl, l-piperazinyl and l-piperidinyl.
3. 2-trifluoromethyl-10-{2-[2-(1-pyrrolidyl)-lower kyleneoxy]propyl}-phenothiazine.
4. 2 trifluoromethyl-lO-{Z-[2-(1-pyrr01idy1)-ethoxy]- propyl}-phenothiazine.
5. Z-trifluorornethyl-lO-{Z-[2-(4-methyl-1-piperaziny1)- ethoxy]-propy1}-phenothiazine citrate.
References Cited by the Examiner UNITED STATES PATENTS Cusic 260243 Von Seemann 260-243 Jacob et a1 260243 Gailliot et a1 260243 Gailliot et a1. 260243 Jacob et a1. 260243 12 2,928,767 3/1960 Gulesich et a1. 260243 2,976,286 3/1961 Schindler et a1. 260243 FOREIGN PATENTS 5 213,402 2/1961 Australia.
786,384 11/1957 Great Britain.
OTHER REFERENCES Schmitt et a1.: Bull. Soc. Chim., France, 1957, page 10 939.
WALTER A. MODANCE, Primary Examiner.
IRVING MARCUS, Examiner.
Claims (2)
1. 2-TRIFLUOROMETHYL-10-(2-((4-LOWER ALKYL - 1 - PIPERAZINYL)-LOWER ALKYLENEOXY)-PROPYL)-PHENOTHIAZINE.
2. A COMPOUND SELECTED FROM THE GROUP CONSISTING OF COMPOUNDS OF THE FORMULA
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91603A US3238199A (en) | 1961-02-27 | 1961-02-27 | Phenothiazine compounds |
| BE614129A BE614129A (en) | 1961-02-27 | 1962-02-20 | Process for the preparation of phenothiazine derivatives. |
| ES0274967A ES274967A1 (en) | 1961-02-27 | 1962-02-26 | Procedure for the manufacture of new fenotiazine compounds (Machine-translation by Google Translate, not legally binding) |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91603A US3238199A (en) | 1961-02-27 | 1961-02-27 | Phenothiazine compounds |
| US95467A US3148156A (en) | 1961-03-14 | 1961-03-14 | Phthalocyanine catalyst regeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3238199A true US3238199A (en) | 1966-03-01 |
Family
ID=26784129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US91603A Expired - Lifetime US3238199A (en) | 1961-02-27 | 1961-02-27 | Phenothiazine compounds |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3238199A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5269954A (en) * | 1988-12-05 | 1993-12-14 | Elf France | Nitrogenous additives with an antioxidant action and lubricating compositions containing the said additives |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2650919A (en) * | 1953-09-01 | Basic esters of phenothiazine-io-car | ||
| US2779824A (en) * | 1952-08-29 | 1957-01-29 | Ericsson Telefon Ab L M | Identifier |
| GB786384A (en) * | 1955-01-31 | 1957-11-20 | Ayerst Mckenna & Harrison | Basic alkoxyalkyl esters of phenothiazine-10-carboxylic acid and process for preparing same |
| US2877224A (en) * | 1955-11-15 | 1959-03-10 | Rhone Poulenc Sa | 3-cyano substituted phenothiazines |
| US2891952A (en) * | 1956-07-19 | 1959-06-23 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2898336A (en) * | 1957-04-11 | 1959-08-04 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2908683A (en) * | 1957-01-15 | 1959-10-13 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2928767A (en) * | 1957-07-17 | 1960-03-15 | Smith Kline French Lab | Stabilized phenothiazine preparations |
| US2976286A (en) * | 1961-03-21 | Basically substituted piffinothiazine |
-
1961
- 1961-02-27 US US91603A patent/US3238199A/en not_active Expired - Lifetime
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2650919A (en) * | 1953-09-01 | Basic esters of phenothiazine-io-car | ||
| US2976286A (en) * | 1961-03-21 | Basically substituted piffinothiazine | ||
| US2779824A (en) * | 1952-08-29 | 1957-01-29 | Ericsson Telefon Ab L M | Identifier |
| GB786384A (en) * | 1955-01-31 | 1957-11-20 | Ayerst Mckenna & Harrison | Basic alkoxyalkyl esters of phenothiazine-10-carboxylic acid and process for preparing same |
| US2877224A (en) * | 1955-11-15 | 1959-03-10 | Rhone Poulenc Sa | 3-cyano substituted phenothiazines |
| US2891952A (en) * | 1956-07-19 | 1959-06-23 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2908683A (en) * | 1957-01-15 | 1959-10-13 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2898336A (en) * | 1957-04-11 | 1959-08-04 | Rhone Poulenc Sa | Phenthiazine derivatives |
| US2928767A (en) * | 1957-07-17 | 1960-03-15 | Smith Kline French Lab | Stabilized phenothiazine preparations |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5269954A (en) * | 1988-12-05 | 1993-12-14 | Elf France | Nitrogenous additives with an antioxidant action and lubricating compositions containing the said additives |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2921069A (en) | Substituted trifluroromethylpheno-thiazine derivatives | |
| US3058979A (en) | New perfluoroalkylphenothiazine derivatives | |
| US2902484A (en) | Phenthiazine derivatives and processes for their preparation | |
| PL69767B1 (en) | 11-substituted 5 11-dihydro-6h-pyrido(2 3-b)(1 4)benzodiazepin-6-ones [us3660380a] | |
| US2852510A (en) | Heterocyclic compounds and process for producing same | |
| US2650919A (en) | Basic esters of phenothiazine-io-car | |
| US2877224A (en) | 3-cyano substituted phenothiazines | |
| US4377576A (en) | 5-(Heterocyclic amino-propionyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones | |
| US2931810A (en) | Phenothiazine derivatives | |
| US3923813A (en) | Derivatives of 2-aminoindanes | |
| US2889322A (en) | 3-methanesulphonyl phenthiazine derivatives | |
| US2694705A (en) | Nx c c ox a a | |
| US3227716A (en) | Therapeutically-active dibenzocycloheptane derivatives | |
| US3043842A (en) | Substituted acridans | |
| US3479346A (en) | N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines | |
| US2898336A (en) | Phenthiazine derivatives | |
| US2956996A (en) | Alkylated phenotfflazenecarboxamede | |
| US2979502A (en) | Phenthiazine derivatives | |
| US3238199A (en) | Phenothiazine compounds | |
| US2944054A (en) | Substituted phenothiazinylalkyl aminosulfonylpiperazines | |
| US2908683A (en) | Phenthiazine derivatives | |
| US2894947A (en) | Phenthiazine derivatives | |
| US2800474A (en) | 9-(piperazinoalkyl) norharman derivatives | |
| US4046778A (en) | Processes for the preparation of 4-hydroxy-2H-1-benzothiopyran-3-carboxamide 1,1-dioxides | |
| US2997468A (en) | Preparation of phenothiazines |